脑细胞激活素药物的化学成分分析

采用日本岛津LC-60A型高压液相色谱仪和美国P-E3030型原子吸收分光光度计，对该药进行了氨基酸、维生素和化学元素的含量测定。结果表明，该药含有18种氨基酸，不少于3种维生素和20几种化学元素，为进一步改进该药物的合理配制方法和临床应用提供了参考数据。     

Characterization of CNS disorders and evaluation of therapy using structural and functional MRI

Modern drug development requires technologies that allow rapid translation from the preclinical to the clinical stage. It is obvious that non-invasive imaging modalities such as magnetic resonance imaging (MRI) will play a central role in this regard. This article reviews the use of structural and functional MRI readouts for characterization of central nervous system (CNS) disorders and evaluation of the efficacy of potential CNS drugs. Examples comprise dementia of Alzheimer's type, cerebral ischemia, and neuroinflammation covering both clinical and preclinical aspects. In these examples MRI has been used to obtain relevant structural information on brain atrophy, on the location and extent of ischemic brain areas, and on the number and distribution of demyelinated plaques. These structural data are complemented by readouts assessing the functional consequences associated with the pathomorphological changes. In the last decade, MRI has evolved into a standard tool for the development of CNS drugs. With regard to target-specific/molecular imaging applications MRI is limited by its inherently low sensitivity; complementary imaging modalities utilizing optical and radionuclear reporter systems will thus be required.     

急性脑血管病患者血清元素的测定

采用高频等离子体发射光谱法测定了３４例脑梗塞、３３例脑出血和对照组２７人血清锌、铜、锰、铬、镁、钼、锶、铁、钛、钡、镉和钙共１２种元素的含量。结果显示脑梗塞和脑出血组血清锌和锌／铜比值显著高于对照组；锰和钼含量仅在脑梗塞组明显增高，锶仅在脑出血组显著增高，而其它几种元素疾病组与对照组无显著性差异。伴有高血糖、高血脂和高血压的病人，其血铬含量显著降低，表明锌、锌／铜比值、锰、钼、锶、铬元素与急性脑血     

综合治疗脑梗塞68例观察

脑梗塞是常见病，且大部分可引起偏瘫，失语，智能障碍等后遗症，严重影响病人的生存质量，广州市第六人民医院于１９９５年１月～１９９７年６月采用中西药物，传统治疗，功能障碍治疗，心理治疗，氦氖激光血管内照射，血液光量子疗法，高压氧等综合治疗脑梗塞６８例，总疗程３个月，结果，总有效率９４．１％，显效率６４．１％，明显高于单用药物治疗的显效率，说明综合治疗可提高疗效，减少后遗症及致残率，且病程越短，疗效越好     

Sigma-1 Receptor Agonist TS-157 Improves Motor Functional Recovery by Promoting Neurite Outgrowth and pERK in Rats with Focal Cerebral Ischemia

Sigma-1 (σ-1) receptor agonists are considered as potential treatment for stroke. TS-157 is an alkoxyisoxazole-based σ-1 receptor agonist previously discovered in our group. The present study describes TS-157 profile in a battery of tests for cerebral ischemia. Initial evaluation demonstrated the compound’s safety profile and blood–brain barrier permeability, as well as its ability to induce neurite outgrowth in vitro. The neurite outgrowth was shown to be mediated via σ-1 receptor agonism and involves upregulation of ERK phosphorylation (pERK). In particular, TS-157 also significantly accelerated the recovery of motor function in rats with transient middle cerebral artery occlusion (tMCAO). Overall, the results herein support the notion that σ-1 receptor agonists are potential therapeutics for stroke and further animal efficacy studies are warranted.     

TRPV1 Contributes to Modulate the Nitric Oxide Pathway and Oxidative Stress in the Isolated and Perfused Rat Heart during Ischemia and Reperfusion

The transient vanilloid receptor potential type 1 (TRPV1) regulates neuronal and vascular functions mediated by nitric oxide (NO) and by the calcitonin gene-related peptide (CGRP). Here, we study the participation of TRPV1 in the regulation of myocardial injury caused by ischemia-reperfusion and in the control of NO, tetrahydrobiopterin (BH4), the cGMP pathway, CGRP, total antioxidant capacity (TAC), malondialdehyde (MDA) and phosphodiesterase-3 (PDE-3). Isolated hearts of Wistar rats perfused according to the Langendorff technique were used to study the effects of an agonist of TRPV1, capsaicin (CS), an antagonist, capsazepine (CZ), and their combination CZ+CS. The hearts were subjected to three conditions: (1) control, (2) ischemia and (3) ischemia-reperfusion. We determined cardiac mechanical activity and the levels of NO, cGMP, BH4, CGRP, TAC, MDA and PDE-3 in ventricular tissue after administration of CS, CZ and CZ+CS. Western blots were used to study the expressions of eNOS, iNOS and phosphorylated NOS (pNOS). Structural changes were determined by histological evaluation. CS prevented damage caused by ischemia-reperfusion by improving cardiac mechanical activity and elevating the levels of NO, cGMP, BH4, TAC and CGRP. TRPV1 and iNOS expression were increased under ischemic conditions, while eNOS and pNOS were not modified. We conclude that the activation of TRPV1 constitutes a therapeutic possibility to counteract the damage caused by ischemia and reperfusion by regulating the NO pathway through CGRP.     

促红细胞生成素B螺旋表面肽的代谢稳定性结构修饰：设计、合成及其提高的肾保护作用

肾脏缺血缺氧以及再灌注过程都将导致肾小管上皮细胞凋亡,使肾功能严重受损.肾脏的缺血再灌注损伤是移植肾功能延迟恢复的主要原因并能诱导急慢性排斥,影响肾存活率.近年来发现,衍生于促红细胞生成素（EPO）的B螺旋亚基亲水表面序列的肽链（HBSP）,对肾脏缺血再灌注损伤具有显著的保护作用,但其在体内极短的半衰期（约2min）极大地限制了它的临床应用.因此,本研究采用构象约束、全D-构型氨基酸替换和N-端封闭策略,设计了3种类型的EPOB螺旋表面肽衍生物,旨在提高其代谢稳定性环肽的设计采用了对氧化还原稳定的硫醚键和相对刚性的亚砜键两种环合方式.在多肽的合成上,采用微波辅助多肽自动合成和手工合成两种模式有机结合;优化了硫醚环合工艺,应用微波加热进行硫醚环肽的合成,大大提高了产率和效率;利用圆二色（CD）谱确定了亚砜环肽的相对构型.活性实验表明,相对于线性母肽HBSP,本文设计合成的代谢稳定衍生肽对大/小鼠肾脏缺血再灌注损伤均有显著提高的保护作用,且硫醚和R-构型亚砜环肽的肾脏保护活性强于S-构型亚砜环肽.而且,环化确实提高了功能肽的血浆稳定性.因此,本文合成的硫醚环肽一周一次注射剂量等效于线性肽HBSP一日三次剂量对小鼠肾损伤的保护作用.     

川芎嗪对脑缺血下大鼠纹状体区痕量氨基酸类神经递质的影响

采用脑内微透析技术结合激光诱导荧光检测的高效毛细管电泳研究了脑缺血下盐酸川芎嗪注射液对大鼠纹状体区氨基酸类神经递质含量的影响.在优化的分离条件下,各氨基酸在1×10^-6-1×10^-8mol/L的浓度范围内与荧光强度呈良好的线性关系,线性相关系数达到0.99以上,检测限低于1.6×10^-9mol/L,适合于大鼠纹状体区微透析样品中的痕量氨基酸类神经递质的测量.实验结果表明,脑缺血时,使用盐酸川芎嗪注射液可显著降低细胞外兴奋性氨基酸神经递质谷氮酸(G lu)和天门冬氨酸(Asp)的浓度(P<0.05),同时可显著升高抑制性氨基酸神经递质γ-氨基丁酸(GABA)和甘氨酸(G ly)的浓度(P<0.05).这一结果将对阐明盐酸川芎嗪注射液治疗缺血性脑血管疾病的有关机理提供帮助.     

毛冬青总皂苷对大鼠脑缺血再灌注损伤的保护作用及血液微量元素影响

目的研究毛冬青总皂苷对脑缺血再灌注损伤的保护作用,并初步探讨其血液微量元素的影响。方法动物随机分为假手术组、模型组、毛冬青总皂苷(高、中、低)剂量组及阳性药物对照组,运用大鼠大脑中动脉栓塞,制作脑缺血再灌注损伤模型,缺血10 min后,给药组及阳性药物组于舌下静脉给予高、中、低剂量的毛冬青总皂苷及假手术组、模型组给予等体积的溶剂。缺血60 min再灌注24 h后,每组取8只大鼠断头取脑,TTC染色,测定脑梗死体积;取血,测定血液中3种微量元素Ca、Zn、Cu的含量。结果毛冬青总皂苷组与模型组相比,毛冬青总皂苷治疗组脑梗死体积减小,病理变化较轻;模型组与假手术组比较血液中Ca、Cu含量增加明显有统计学意义,Zn含量明显降低与假手术组比较有统计学意义(P0.05),毛冬青高、中、低剂量组与模型组比较Ca、Cu含量明显降低,Zn含量明显升高,而且呈明显的量效关系,与模型组比较有统计学意义(P0.05)。结论毛冬青总皂苷对脑缺血再灌注损伤具有一定的保护作用,其保护机制与毛冬青总皂苷抗氧化作用及增强氧自由基的清除有关。     

Antioxidant Cardioprotection against Reperfusion Injury: Potential Therapeutic Roles of Resveratrol and Quercetin

Ischemia-reperfusion myocardial damage is a paradoxical tissue injury occurring during percutaneous coronary intervention (PCI) in acute myocardial infarction (AMI) patients. Although this damage could account for up to 50% of the final infarct size, there has been no available pharmacological treatment until now. Oxidative stress contributes to the underlying production mechanism, exerting the most marked injury during the early onset of reperfusion. So far, antioxidants have been shown to protect the AMI patients undergoing PCI to mitigate these detrimental effects; however, no clinical trials to date have shown any significant infarct size reduction. Therefore, it is worthwhile to consider multitarget antioxidant therapies targeting multifactorial AMI. Indeed, this clinical setting involves injurious effects derived from oxygen deprivation, intracellular pH changes and increased concentration of cytosolic Ca²⁺ and reactive oxygen species, among others. Thus, we will review a brief overview of the pathological cascades involved in ischemia-reperfusion injury and the potential therapeutic effects based on preclinical studies involving a combination of antioxidants, with particular reference to resveratrol and quercetin, which could contribute to cardioprotection against ischemia-reperfusion injury in myocardial tissue. We will also highlight the upcoming perspectives of these antioxidants for designing future studies.